PAR 0.00% 21.0¢ paradigm biopharmaceuticals limited..

PAR. SP, page-757

  1. 692 Posts.
    lightbulb Created with Sketch. 130
    This is an extract from a CHN (mining) announcement this morning:

    22 January 2024
    Corporate update

    Highlights

    « In light of current weak market conditions, a further expenditure review has been completed and
    2024 expenditures are expected to reduce by ~40% relative to 2023:
    «
    Material reductions in executive salaries, director fees and other corporate costs, plus a
    rationalisation of the Company’s management structure, has driven a ~$2.2Mp.a. decrease
    in corporate overheads.


    This is responsible governance, no?
    Last edited by Babbanap: 22/01/24
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.